Aberdeen Group
GRTX

Aberdeen Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Aberdeen Group’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-898,374
Closed -$126K – 984
2024
Q1 		$126K Hold
898,374
– – ﹤0.01% 939
2023
Q4 		$131K Buy
+898,374
New +$140K ﹤0.01% 953

Other funds holding GRTX

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Aberdeen Group's GRTX Position: Q2 2024 in Review

Aberdeen Group sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 898,374 shares — an estimated $126K sold.

Aberdeen Group first reported a position in GRTX in Q4 2023 and held it in 2 quarters. The position peaked at $131K in Q4 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Aberdeen Group reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Aberdeen Group sold 898,374 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $126K.
  • Aberdeen Group first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Aberdeen Group's Galera Therapeutics, Inc. Common Stock position peaked at $131K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Aberdeen Group's 13F filing for Q2 2024, filed 9 Aug 2024.